Mylan has set its sights on bringing generic versions of three top-selling insulin brands to market. The company has signed a collaboration deal with Biocon to develop and commercialise the Indian ...
PRINCETON, N.J. Novo Nordisk has received approval from the Food and Drug Administration for its insulin drug NovoLog to be used in external, subcutaneous insulin pumps by children and adolescents ...
Mylan has entered into a definitive agreement with Biocon Limited for an exclusive collaboration on the development and commercialization of generic versions of three insulin analog products. Mylan ...
BRIDGEWATER, N.J., March 1, 2011 /PRNewswire/ -- Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today ...
Last week, Eli Lilly announced it was introducing a lower-priced authorized generic - a repackaged version of the brand - of its rapidly acting insulin lispro injection (Humalog) in the U.S.. The ...
People with diabetes were notified the other day by insurance giant UnitedHealthcare that one of the most widely prescribed insulins, NovoLog, is switching from the company's Tier 1 drug list to Tier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback